Published in Am J Gastroenterol on February 09, 2010
Noninvasive Markers of Gluten Ingestion in Celiac Disease Patients | NCT02389062
ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol (2013) 4.36
Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc (2012) 3.60
Mucosal healing and mortality in coeliac disease. Aliment Pharmacol Ther (2012) 3.57
Patients with celiac disease are not followed up adequately. Clin Gastroenterol Hepatol (2012) 2.78
Persistence of elevated deamidated gliadin peptide antibodies on a gluten-free diet indicates nonresponsive coeliac disease. Aliment Pharmacol Ther (2014) 2.67
Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut (2014) 2.36
Cysteinyl leukotrienes mediate lymphokine killer activity induced by NKG2D and IL-15 in cytotoxic T cells during celiac disease. J Exp Med (2015) 1.62
Capsule endoscopy in nonresponsive celiac disease. Gastrointest Endosc (2011) 1.54
Essential amino acids in the gluten-free diet and serum in relation to depression in patients with celiac disease. PLoS One (2015) 1.42
Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease. Gut (2012) 1.37
Safety, tolerability, and activity of ALV003: results from two phase 1 single, escalating-dose clinical trials. Dig Dis Sci (2011) 1.21
Advances in diagnosis and management of celiac disease. Gastroenterology (2015) 1.17
Predictors of persistent villous atrophy in coeliac disease: a population-based study. Aliment Pharmacol Ther (2014) 1.15
IL-15: a central regulator of celiac disease immunopathology. Immunol Rev (2014) 1.14
Validation of morphometric analyses of small-intestinal biopsy readouts in celiac disease. PLoS One (2013) 1.13
Clinical features and symptom recovery on a gluten-free diet in Canadian adults with celiac disease. Can J Gastroenterol (2013) 1.12
Mucosal healing and risk for lymphoproliferative malignancy in celiac disease: a population-based cohort study. Ann Intern Med (2013) 1.11
The gluten-free diet and its current application in coeliac disease and dermatitis herpetiformis. United European Gastroenterol J (2015) 1.06
A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge. Am J Gastroenterol (2012) 1.05
Review article: coeliac disease, new approaches to therapy. Aliment Pharmacol Ther (2012) 1.04
Update on celiac disease - etiology, differential diagnosis, drug targets, and management advances. Clin Exp Gastroenterol (2011) 0.97
Celiac disease diagnosis and management: a 46-year-old woman with anemia. JAMA (2011) 0.93
Celiac disease and non-celiac gluten sensitivity. BMJ (2015) 0.93
Patients with celiac disease have a lower prevalence of non-insulin-dependent diabetes mellitus and metabolic syndrome. Gastroenterology (2013) 0.91
Interest in medical therapy for celiac disease. Therap Adv Gastroenterol (2013) 0.90
Small- bowel mucosal changes and antibody responses after low- and moderate-dose gluten challenge in celiac disease. BMC Gastroenterol (2011) 0.89
Persistent mucosal damage and risk of fracture in celiac disease. J Clin Endocrinol Metab (2014) 0.88
Diagnosis of celiac disease. Gastrointest Endosc Clin N Am (2012) 0.88
Predictors of persistent symptoms and reduced quality of life in treated coeliac disease patients: a large cross-sectional study. BMC Gastroenterol (2013) 0.88
The potential utility of tight junction regulation in celiac disease: focus on larazotide acetate. Therap Adv Gastroenterol (2016) 0.86
Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial. Gastroenterology (2015) 0.86
Development of drugs for celiac disease: review of endpoints for Phase 2 and 3 trials. Gastroenterol Rep (Oxf) (2015) 0.85
Practical insights into gluten-free diets. Nat Rev Gastroenterol Hepatol (2015) 0.85
Mucosal healing and the risk of ischemic heart disease or atrial fibrillation in patients with celiac disease; a population-based study. PLoS One (2015) 0.84
DHA serum levels were significantly higher in celiac disease patients compared to healthy controls and were unrelated to depression. PLoS One (2014) 0.83
Support for patients with celiac disease: A literature review. United European Gastroenterol J (2015) 0.83
The management of refractory coeliac disease. Ther Adv Chronic Dis (2013) 0.83
Predictors and Significance of Incomplete Mucosal Recovery in Celiac Disease After 1 Year on a Gluten-Free Diet. Am J Gastroenterol (2015) 0.82
Celiac disease and persistent symptoms. Clin Gastroenterol Hepatol (2010) 0.81
Age-related differences in celiac disease: Specific characteristics of adult presentation. World J Gastrointest Pharmacol Ther (2015) 0.79
Mucosal healing in patients with celiac disease and outcomes of pregnancy: a nationwide population-based study. Clin Gastroenterol Hepatol (2014) 0.79
The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet. Semin Immunopathol (2012) 0.78
Capsule endoscopy: a valuable tool in the follow-up of people with celiac disease on a gluten-free diet. Clin Transl Gastroenterol (2011) 0.78
Patients with celiac disease and B-cell lymphoma have a better prognosis than those with T-cell lymphoma. Clin Gastroenterol Hepatol (2010) 0.77
Barriers impeding serologic screening for celiac disease in clinically high-prevalence populations. BMC Gastroenterol (2014) 0.77
Follow-up of pediatric celiac disease: value of antibodies in predicting mucosal healing, a prospective cohort study. BMC Gastroenterol (2014) 0.77
Despite sequence homologies to gluten, salivary proline-rich proteins do not elicit immune responses central to the pathogenesis of celiac disease. Am J Physiol Gastrointest Liver Physiol (2015) 0.77
Creation of a model to predict survival in patients with refractory coeliac disease using a multinational registry. Aliment Pharmacol Ther (2016) 0.77
Application of Deamidated Gliadin Antibodies in the Follow-Up of Treated Celiac Disease. PLoS One (2015) 0.76
Serum markers in the clinical management of celiac disease. Dig Dis (2015) 0.76
Current Status of Celiac Disease Drug Development. Am J Gastroenterol (2016) 0.75
Improving outcomes of refractory celiac disease - current and emerging treatment strategies. Clin Exp Gastroenterol (2016) 0.75
Outcome of Referrals for Non-Responsive Celiac Disease in a Tertiary Center: Low Incidence of Refractory Celiac Disease in the Netherlands. Clin Transl Gastroenterol (2017) 0.75
Serum I-FABP Detects Gluten Responsiveness in Adult Celiac Disease Patients on a Short-Term Gluten Challenge. Am J Gastroenterol (2016) 0.75
Biomarkers to Monitor Gluten-Free Diet Compliance in Celiac Patients. Nutrients (2017) 0.75
Prevalence and Morbidity of Undiagnosed Celiac Disease From a Community-based Study. Gastroenterology (2016) 0.75
Managing the pediatric patient with celiac disease: a multidisciplinary approach. J Multidiscip Healthc (2016) 0.75
Celiac Disease: Diagnostic Standards and Dilemmas. Diseases (2015) 0.75
Clinical and genetic profile of patients with seronegative coeliac disease: the natural history and response to gluten-free diet. BMJ Open Gastroenterol (2017) 0.75
Flow cytometry of duodenal intraepithelial lymphocytes improves diagnosis of celiac disease in difficult cases. United European Gastroenterol J (2016) 0.75
Association of Autoimmune Hepatitis and Celiac Disease: Role of Gluten-Free Diet in Reversing Liver Dysfunction. J Investig Med High Impact Case Rep (2017) 0.75
Celiac disease. N Engl J Med (2007) 10.98
Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology (1992) 10.44
Prevalence of Celiac disease among children in Finland. N Engl J Med (2003) 7.27
The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol (1999) 6.27
Malignancy in coeliac disease--effect of a gluten free diet. Gut (1989) 5.58
American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology (2006) 4.41
Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology (2009) 3.73
Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet (2000) 3.47
Small-intestinal histopathology and mortality risk in celiac disease. JAMA (2009) 3.35
Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet (2001) 3.28
Coeliac disease--associated disorders and survival. Gut (1994) 3.13
Duodenal histology in patients with celiac disease after treatment with a gluten-free diet. Gastrointest Endosc (2003) 3.11
Advances in celiac disease and gluten-free diet. J Am Diet Assoc (2008) 2.82
Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology (2008) 2.39
Long-term follow-up of 61 coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet. Gut (2007) 2.34
Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ (2004) 2.29
Lymphocytic duodenosis and the spectrum of celiac disease. Am J Gastroenterol (2009) 2.26
Mortality in celiac disease. Gastroenterology (1989) 2.24
Childhood celiac disease: a long-term analysis of relapses in 91 patients. J Pediatr Gastroenterol Nutr (1986) 2.14
Mucosal atrophy in celiac disease: extent of involvement, correlation with clinical presentation, and response to treatment. Clin Gastroenterol Hepatol (2007) 2.07
Effect of a gluten-free diet on gastrointestinal symptoms in celiac disease. Am J Clin Nutr (2004) 1.97
Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study. Gastroenterology (2008) 1.93
Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med (2003) 1.88
Coeliac disease and risk of sepsis. Gut (2008) 1.86
Lack of correlation of degree of villous atrophy with severity of clinical presentation of coeliac disease. Dig Liver Dis (2006) 1.84
Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol (2007) 1.82
Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery. Am J Clin Pathol (2002) 1.81
Risk of non-Hodgkin lymphoma in celiac disease. JAMA (2002) 1.81
Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol (2002) 1.79
Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet. Aliment Pharmacol Ther (2009) 1.72
Long-term follow-up of celiac adults on gluten-free diet: prevalence and correlates of intestinal damage. Digestion (2002) 1.68
Malignancies in cases with screening-identified evidence of coeliac disease: a long-term population-based cohort study. Gut (2008) 1.64
Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology (2008) 1.63
Economic burden of a gluten-free diet. J Hum Nutr Diet (2007) 1.62
Mortality excess in individuals with elevated IgA anti-transglutaminase antibodies: the KORA/MONICA Augsburg cohort study 1989-1998. Eur J Epidemiol (2006) 1.51
Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease. Am J Gastroenterol (2003) 1.48
Significance of intraepithelial lymphocytosis in small bowel biopsy samples with normal mucosal architecture. Am J Gastroenterol (2003) 1.44
Follow-up of patients with celiac disease: achieving compliance with treatment. Gastroenterology (2005) 1.37
Persistent small bowel mucosal villous atrophy without symptoms in coeliac disease. Aliment Pharmacol Ther (2007) 1.33
Better dietary compliance in patients with coeliac disease diagnosed in early childhood. Scand J Gastroenterol (2003) 1.26
Coeliac disease: a histological follow-up study. Histopathology (2007) 1.25
Celiac disease and risk of liver disease: a general population-based study. Clin Gastroenterol Hepatol (2006) 1.21
Systematic review: The evidence base for long-term management of coeliac disease. Aliment Pharmacol Ther (2008) 1.21
Gluten-free diet: the medical and nutrition management of celiac disease. Nutr Clin Pract (2006) 1.19
Persistent mucosal abnormalities in coeliac disease are not related to the ingestion of trace amounts of gluten. Scand J Gastroenterol (1999) 1.14
Need for follow up in coeliac disease. Arch Dis Child (1994) 1.13
Incidence and prevalence of diagnosed coeliac disease in Finland: results of effective case finding in adults. Scand J Gastroenterol (2009) 1.11
Prognosis of unrecognized coeliac disease as regards mortality: a population-based cohort study. Ann Med (2009) 1.04
Complete small intestine mucosal recovery is obtainable in the treatment of celiac disease. Gastrointest Endosc (2004) 1.00
Increased density of jejunal gammadelta+ T cells in patients having normal mucosa--marker of operative autoimmune mechanisms? Autoimmunity (1999) 0.98
Clinical response to gluten withdrawal is not an indicator of coeliac disease. Scand J Gastroenterol (2008) 0.97
Slow and incomplete histological and functional recovery in adult gluten sensitive enteropathy. J Clin Pathol (1988) 0.94
Intraepithelial lymphocytes and coeliac disease. Best Pract Res Clin Gastroenterol (2005) 0.93
Changing jejunal gamma delta T cell receptor (TCR)-bearing intraepithelial lymphocyte density in coeliac disease. Clin Exp Immunol (1999) 0.88
Mortality in celiac disease, intestinal inflammation, and gluten sensitivity. JAMA (2009) 0.88
Changing phenotype of celiac disease after long-term gluten exposure. J Pediatr Gastroenterol Nutr (2008) 0.82
Follow-up of treated adult celiac disease: clinical and morphological studies. Hepatogastroenterology (1982) 0.81
Gluten tolerance in adult patients with celiac disease 20 years after diagnosis? Eur J Gastroenterol Hepatol (2008) 0.81
Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med (2003) 7.80
Multiple common variants for celiac disease influencing immune gene expression. Nat Genet (2010) 6.90
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol (2006) 5.78
The Oslo definitions for coeliac disease and related terms. Gut (2012) 5.76
Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr (2005) 5.34
The prevalence of celiac disease in the United States. Am J Gastroenterol (2012) 4.77
American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology (2006) 4.41
ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol (2013) 4.36
Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology (2009) 3.73
Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc (2012) 3.60
A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function. Gastroenterology (2013) 3.56
Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association's endocarditis prevention guidelines. Circulation (2012) 2.97
Patients with celiac disease are not followed up adequately. Clin Gastroenterol Hepatol (2012) 2.78
Drastic down-regulation of Krüppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res (2005) 2.67
Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer (2005) 2.49
The incidence and risk of celiac disease in a healthy US adult population. Am J Gastroenterol (2012) 2.47
Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol (2002) 2.35
Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma. Clin Cancer Res (2003) 2.28
Lymphocytic duodenosis and the spectrum of celiac disease. Am J Gastroenterol (2009) 2.26
Culture-negative prosthetic joint infection. Clin Infect Dis (2007) 2.13
Increased risk of systemic lupus erythematosus in 29,000 patients with biopsy-verified celiac disease. J Rheumatol (2012) 2.11
Is it necessary to assess for fat-soluble vitamin deficiencies in pediatric patients with newly diagnosed celiac disease? J Pediatr Gastroenterol Nutr (2014) 2.04
The crosstalk of mTOR/S6K1 and Hedgehog pathways. Cancer Cell (2012) 2.02
Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity. Am J Gastroenterol (2009) 2.02
Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study. Gastroenterology (2010) 2.01
Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. Am J Pathol (2002) 1.96
A report on the International Transglutaminase Autoantibody Workshop for Celiac Disease. Am J Gastroenterol (2009) 1.94
Hematologic manifestations of celiac disease. Blood (2006) 1.87
Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study. Mayo Clin Proc (2004) 1.85
Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer. Clin Cancer Res (2004) 1.84
Establishment and characterization of a bona fide Barrett esophagus-associated adenocarcinoma cell line. Cancer Biol Ther (2008) 1.83
Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol (2003) 1.82
The liver in celiac disease. Hepatology (2007) 1.81
Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol (2002) 1.79
Routine duodenal biopsies to exclude celiac disease? Gastrointest Endosc (2003) 1.76
Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Cancer (2007) 1.73
The insensitivity of endoscopic markers in celiac disease. Am J Gastroenterol (2002) 1.70
A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol (2010) 1.70
Increasing incidence of celiac disease in a North American population. Am J Gastroenterol (2013) 1.69
Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms. Clin Gastroenterol Hepatol (2003) 1.66
Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma. Clin Cancer Res (2008) 1.64
A prospective, randomized, double-blind, placebo-controlled trial of endoscopic steroid injection therapy for recalcitrant esophageal peptic strictures. Am J Gastroenterol (2005) 1.64
Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology (2008) 1.63
Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantation. Liver Int (2008) 1.62
Gluten-free diet and steroid treatment are effective therapy for most patients with collagenous sprue. Clin Gastroenterol Hepatol (2010) 1.58
Aortic valve replacement in patients aged 50 to 70 years: improved outcome with mechanical versus biologic prostheses. J Thorac Cardiovasc Surg (2008) 1.56
Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy. J Gastrointest Surg (2003) 1.56
Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. J Clin Oncol (2006) 1.55
Adult intussusception in the last 25 years of modern imaging: is surgery still indicated? J Gastrointest Surg (2011) 1.54
Participation in cardiac rehabilitation and survival after coronary artery bypass graft surgery: a community-based study. Circulation (2013) 1.54
Capsule endoscopy in nonresponsive celiac disease. Gastrointest Endosc (2011) 1.54
Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation response. Clin Cancer Res (2006) 1.52
Duplication of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma. Am J Surg Pathol (2007) 1.52
Anti-bullous pemphigoid 180 and 230 antibodies in a sample of unaffected subjects. Arch Dermatol (2010) 1.52
Screening for celiac disease in a North American population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol (2011) 1.52
Adult autoimmune enteropathy: Mayo Clinic Rochester experience. Clin Gastroenterol Hepatol (2007) 1.51
Celiac disease. Curr Opin Gastroenterol (2010) 1.51
Leukocyte cell-derived chemotaxin 2 (LECT2)-associated amyloidosis is a frequent cause of hepatic amyloidosis in the United States. Blood (2014) 1.50
Training in small-bowel capsule endoscopy: assessing and defining competency. Gastrointest Endosc (2013) 1.50
Comparison of primary and metastatic malignant melanoma of the esophagus: clinicopathologic review of 10 cases. Arch Pathol Lab Med (2008) 1.50
Esophageal function testing with combined multichannel intraluminal impedance and manometry: multicenter study in healthy volunteers. Clin Gastroenterol Hepatol (2003) 1.48
Classification and management of refractory coeliac disease. Gut (2010) 1.48
Pathogen-specific risk of celiac disease following bacterial causes of foodborne illness: a retrospective cohort study. Dig Dis Sci (2013) 1.47
Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc (2010) 1.45
Do claims-based comorbidities adequately capture case mix for surgical site infections? Clin Orthop Relat Res (2014) 1.45
Significance of intraepithelial lymphocytosis in small bowel biopsy samples with normal mucosal architecture. Am J Gastroenterol (2003) 1.44
Pregnancy outcome and risk of celiac disease in offspring: a nationwide case-control study. Gastroenterology (2011) 1.44
The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects. J Am Coll Cardiol (2010) 1.43
Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol (2005) 1.43
Loss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible 0401 mice but not arthritis-resistant 0402 mice. PLoS One (2012) 1.42
Pretherapy nuclear factor-kappaB status, chemoradiation resistance, and metastatic progression in esophageal carcinoma. Mol Cancer Ther (2006) 1.41
Predictors of family risk for celiac disease: a population-based study. Clin Gastroenterol Hepatol (2008) 1.38
Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma. Clin Cancer Res (2005) 1.38
Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am J Surg Pathol (2005) 1.36
"Seedling" mesenchymal tumors (gastrointestinal stromal tumors and leiomyomas) are common incidental tumors of the esophagogastric junction. Am J Surg Pathol (2007) 1.34
Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62 patients. Mayo Clin Proc (2007) 1.34
Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma. J Clin Oncol (2006) 1.33
Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study. Am J Gastroenterol (2011) 1.32
Prior use of antimicrobial therapy is a risk factor for culture-negative prosthetic joint infection. Clin Orthop Relat Res (2010) 1.32
Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation. J Clin Oncol (2005) 1.30
HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J Immunol (2002) 1.30
Morbidity and mortality among older individuals with undiagnosed celiac disease. Gastroenterology (2010) 1.29
Collagenous gastritis: histopathologic features and association with other gastrointestinal diseases. Am J Surg Pathol (2009) 1.29
Incidence of Pseudomonas aeruginosa bacteremia: a population-based study. Am J Med (2008) 1.28